{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"pregerminal-center-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"This form of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) has unmutated immunoglobulin heavy chain variable region (IGHV) genes. IGHV mutational status is one of the biological features used to characterize CLL/SLL.","mondoId":"MONDO:0004478","node":{"canonicalSlug":"pregerminal-center-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"reviewed-summary","matchMethod":"same-ontology-node","name":"pregerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma","paragraphs":["This form of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) has unmutated immunoglobulin heavy chain variable region (IGHV) genes. IGHV mutational status is one of the biological features used to characterize CLL/SLL.","ZAP-70 expression has been described in this subgroup."],"scope":"exact","source":"MONDO","upstream":"NCIT:P378","url":"https://monarchinitiative.org/MONDO:0004478"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"chronic lymphocytic leukemia/small lymphocytic lymphoma","mondoId":"MONDO:0003864","slug":"chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/24026"}],"translation":"published","editorialReview":{"reviewedAt":"2026-10-26","decision":"corrected","reason":"Correct the repeated acronym and use the established unmutated IGHV distinction. Remove the unscoped historical survival number rather than replacing it with another.","sources":["https://www.cancer.gov/types/leukemia/hp/cll-treatment-pdq","https://doi.org/10.1182/BLOOD-2017-09-806398"],"originalNarrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"pregerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma","paragraphs":["A recently recognized variant of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) that lacks somatic hypermutations of the Immunoglobulin heavy chain (IGH) genes, implying pregerminal center B-cell origin. Microarray gene expression profiling studies have demonstrated the expression of ZAP-70 gene (Syk family tyrosine kinase) in this subset of CLL/CLL. Patients with this variant of CLL/SLL have an unfavorable prognosis compared to those with somatic hypermutations of the IGH genes, with a median survival of approximately 6-8 years."],"scope":"exact","source":"MONDO","upstream":"NCIT:P378","url":"https://monarchinitiative.org/MONDO:0004478"},"claimHolds":[]}},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0004478\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>NCIT:P378</dd></dl></details><p class=\"section-source\">Source clarification. <a href=\"https://www.cancer.gov/types/leukemia/hp/cll-treatment-pdq\" rel=\"noreferrer\">1</a> · <a href=\"https://doi.org/10.1182/BLOOD-2017-09-806398\" rel=\"noreferrer\">2</a></p>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>This form of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) has unmutated immunoglobulin heavy chain variable region (IGHV) genes. IGHV mutational status is one of the biological features used to characterize CLL/SLL.</p><p>ZAP-70 expression has been described in this subgroup.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0004478\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"pregerminal-center-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma","sourceDocuments":[{"name":"MONDO: pregerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0004478"}],"sourceNote":"","synonyms":["chronic lymphocytic leukemia/small lymphocytic lymphoma with unmutated Immunoglobulin heavy chain variable-region Gene","CLL/SLL with unmutated IGVH","pregerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma"],"takeawayHtml":"","title":"pregerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma"},"schemaVersion":1}
